Lista de obras -

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

artículo científico publicado en 2018

A novel B-cell line (U-2932) established from a patient with diffuse large B-cell lymphoma following Hodgkin lymphoma

artículo científico publicado en 2002

A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas

artículo científico publicado en 2003

A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival

artículo científico publicado en 2013

A population-based study of cellular markers in R-CHOP treated diffuse large B-cell lymphoma patients

artículo científico publicado en 2016

A population-based study of the outcome for patients with first relapse of Hodgkin's lymphoma

artículo científico publicado en 2002

A5.27 Ro52 Expression is a Prognostic Factor for Survival in B Cell Lymphoma

Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.

artículo científico publicado en 2016

An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome

artículo científico publicado en 2017

Autoimmune disease in patients with diffuse large B-cell lymphoma: occurrence and impact on outcome

artículo científico publicado en 2019

BCL2 expression in de novo diffuse large B-cell lymphoma partly reflects normal differences in age distribution

artículo científico publicado en 2009

Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.

artículo científico publicado en 2009

Both CD4+ FoxP3+ and CD4+ FoxP3- T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro

artículo científico publicado en 2011

Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB.

artículo científico publicado en 2003

CAR T-Cell Therapy: The Role of Physical Barriers and Immunosuppression in Lymphoma

artículo científico publicado en 2015

CD30 expression and survival in posttransplant lymphoproliferative disorders

artículo científico publicado en 2020

CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma

artículo científico publicado en 2007

Cancer of the parotid gland; long-term follow-up. A single centre experience on recurrence and survival

artículo científico publicado en 2009

Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma

artículo científico publicado en 2019

Cernunnos influences human immunoglobulin class switch recombination and may be associated with B cell lymphomagenesis

artículo científico publicado en 2012

Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis

scholarly article by Eva Baecklund et al published 2006 in Arthritis and Rheumatism

Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study

artículo científico publicado en 2016

Chromosomal imbalances in diffuse large B-cell lymphoma detected by comparative genomic hybridization

artículo científico publicado en 2002

Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope.

artículo científico publicado en 2003

Classification of diffuse large B-cell lymphoma by immunohistochemistry demonstrates that elderly patients are more common in the non-GC subgroup and younger patients in the GC subgroup

artículo científico publicado en 2012

Clonal development of a blastoid mantle cell lymphoma studied with comparative genomic hybridization

artículo científico publicado en 2002

Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

artículo científico publicado en 2020

Coding variants at hexa-allelic amino acid 13 of HLA-DRB1 explain independent SNP associations with follicular lymphoma risk

artículo científico publicado en 2013

Core needle biopsies for the diagnosis of diffuse large B-cell lymphoma - a great concern for research

scientific article published on 31 October 2016

DNA repair genes are selectively mutated in diffuse large B cell lymphomas

artículo científico publicado en 2013

Difficulties and bureaucracy threat against clinical research

scientific article published on 01 June 2010

Diffuse Large B Cell Lymphoma Cell Line U-2946: Model for MCL1 Inhibitor Testing

artículo científico publicado en 2016

Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome?

artículo científico publicado en 2018

Early and intermediate stage Hodgkin's lymphoma--report from the Swedish National Care Programme

artículo científico publicado en 2003

Effect of eosinophil cationic protein (ECP) on Hodgkin lymphoma cell lines

artículo científico publicado en 2011

Establishment of a cell line from a chemotherapy resistant diffuse large B-cell lymphoma

artículo científico publicado en 2007

Estrogen receptor β1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker

artículo científico publicado en 2016

Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis

artículo científico publicado en 2005

Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients.

artículo científico publicado en 2014

Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue

scientific article published on 01 November 2003

Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma

scientific article published in PLoS ONE

Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation

scientific article published on 22 July 2018

Expression of intratumoral forkhead box protein 3 in posttransplant lymphoproliferative disorders: clinical features and survival outcomes.

artículo científico publicado en 2015

Expression of possible targets for new proteasome inhibitors in diffuse large B-cell lymphoma

artículo científico publicado en 2016

Expression of ribosomal and actin network proteins and immunochemotherapy resistance in diffuse large B cell lymphoma patients.

artículo científico publicado en 2018

Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis

scholarly article by Eva Baecklund et al published April 2008 in British Journal of Haematology

Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapy

artículo científico publicado en 2019

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma

artículo científico publicado en 2016

Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia

artículo científico publicado en 2015

Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma

artículo científico publicado en 2008

Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas

artículo científico publicado en 2016

Genetic variation in tumor necrosis factor and risk of diffuse large B-cell lymphoma and follicular lymphoma: differences between subgroups in Swedish patients

artículo científico publicado en 2010

Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma

artículo científico publicado en 2006

High Posttransplant Cancer Incidence in Renal Transplanted Patients With Pretransplant Cancer

artículo científico publicado en 2016

High expression of microRNA-200c predicts poor clinical outcome in diffuse large B-cell lymphoma

artículo científico publicado en 2012

High proportions of PD-1 and PD-L1 leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome

artículo científico publicado en 2017

High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms

artículo científico publicado en 2018

Hodgkin lymphoma--a survey of children and adolescents treated in Sweden 1985-2009.

artículo científico publicado en 2014

Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade

artículo científico publicado en 2014

IL-9 expression contributes to the cellular composition in Hodgkin lymphoma

artículo científico publicado en 2006

In vitro and in vivo activity of melflufen (J1)in lymphoma

artículo científico publicado en 2016

Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden

scientific article published on 07 January 2021

Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000-2013.

artículo científico publicado en 2017

LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma

scholarly article by Eva Baecklund et al published 28 February 2011 in Leukemia & Lymphoma

Long term risk of infections in Hodgkin lymphoma long‐term survivors ⬇️

artículo científico publicado el 7 de abril de 2011

Long-term risk of cardiovascular disease in Hodgkin lymphoma survivors--retrospective cohort analyses and a concept for prospective intervention

scientific article published on 01 April 2009

Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma

artículo científico publicado en 2018

Low expression of microRNA-129-5p predicts poor clinical outcome in diffuse large B cell lymphoma (DLBCL)

artículo científico publicado en 2013

Male gender is an adverse risk factor only in young patients with diffuse large B-cell lymphoma - a Swedish population-based study

artículo científico publicado en 2015

Malignancies in transplanted patients: Multidisciplinary evaluation and switch to mTOR inhibitors after kidney transplantation - experiences from a prospective, clinical, observational study

artículo científico publicado en 2016

Malignant lymphoma in granulomatosis with polyangiitis: subtypes, clinical characteristics and prognosis

artículo científico publicado en 2019

Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion

artículo científico publicado en 2006

Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma

artículo científico publicado en 2002

Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma

artículo científico publicado en 2007

Molecular cytogenetic characterization of four commonly used cell lines derived from Hodgkin lymphoma

artículo científico publicado en 2003

Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma

artículo científico publicado en 2003

No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy

artículo científico publicado en 2019

Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma

artículo científico publicado en 2020

Outcome for young high-risk aggressive B-cell lymphoma patients treated with CHOEP-14 and rituximab (R-CHOEP-14)

artículo científico publicado en 2006

Patients above Sixty Years Lymphoma Treated with a New Strategy of Age with Hodgkin's

artículo científico publicado en 2002

Patients above sixty years of age with Hodgkin's lymphoma treated with a new strategy

article published in 2002

Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells

artículo científico publicado en 2015

Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia

artículo científico publicado en 2002

Population-based experience on primary central nervous system lymphoma 2000-2012: the incidence is increasing

artículo científico publicado en 2017

Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma

scientific article published on 25 November 2019

Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin's lymphoma--a population-based study

artículo científico publicado en 2011

Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma

artículo científico publicado en 2019

Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy.

artículo científico publicado en 2007

Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN.

artículo científico publicado en 2007

Quantitative evaluation of p16(INK4a) promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma

artículo científico publicado el 29 de octubre de 2010

Relapsed Hodgkin's lymphoma: immunostaining patterns in relation to survival.

artículo científico publicado en 2002

Relationship between Hodgkin's and Non-Hodgkin's Lymphomas ⬇️

artículo científico publicado el 1 de enero de 2003

Relative and absolute cancer risks among Nordic kidney transplant recipients - a population-based study

artículo científico publicado en 2020

Rheumatoid arthritis, treatment with corticosteroids and risk of malignant lymphomas: results from a case-control study

artículo científico publicado en 2009

Risk Factors for De Novo Squamous Cell Carcinoma Development in Renal Transplant Recipients with a Previous Squamous Cell Carcinoma

artículo científico publicado en 2017

SNP rs6457327 is a predictor for overall survival in follicular lymphoma as well as survival after transformation ⬇️

artículo científico publicado el 20 de octubre de 2011

Sex differences in fertility-related information received by young adult cancer survivors

artículo científico publicado en 2012

Somatic hypermutation and V(H) gene usage in mantle cell lymphoma.

artículo científico publicado en 2002

Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia

artículo científico publicado en 2002

Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia

artículo científico publicado en 2004

T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies

artículo científico publicado en 2010

TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia ⬇️

artículo científico publicado el 25 de septiembre de 2010

TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtype

artículo científico publicado en 2008

Telomere length and correlation with histopathogenesis in B-cell leukemias/lymphomas

scientific article published on 05 February 2007

The MDM2 polymorphism SNP309 is associated with clinical characteristics and outcome in diffuse large B-cell lymphoma

artículo científico publicado en 2014

The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer

artículo científico publicado en 2020

The impact of age on survival of diffuse large B-cell lymphoma - a population-based study.

artículo científico publicado en 2014

The interleukin-10 gene promoter polymorphism (-1082) does not correlate with clinical outcome in diffuse large B-cell lymphoma

artículo científico publicado en 2005

The potential role of innate immunity in the pathogenesis of Hodgkin's lymphoma

artículo científico publicado en 2007

The role of tumour-infiltrating eosinophils, mast cells and macrophages in Classical and Nodular Lymphocyte Predominant Hodgkin Lymphoma in children

artículo científico publicado en 2016

Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma

artículo científico publicado en 2007

Treatment of metastatic malignant melanoma with vemurafenib during pregnancy

artículo científico publicado en 2013

Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib

scientific article published on 22 April 2020

Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients

artículo científico publicado en 2017

Tumoral Pyruvate Kinase L/R as a Predictive Marker for the Treatment of Renal Cancer Patients with Sunitinib and Sorafenib

scientific article published on 02 June 2019

Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib

artículo científico publicado en 2017

U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma

artículo científico publicado en 2006

U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden

artículo científico publicado en 2017

[Kidney transplanted persons with malignant tumors is a growing patient group]

artículo científico publicado en 2012

p53 must be competent for transcriptional regulation to suppress tumor formation

artículo científico publicado en 2005

Lista de obras de

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

A novel B-cell line (U-2932) established from a patient with diffuse large B-cell lymphoma following Hodgkin lymphoma

A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas

A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival

A population-based study of cellular markers in R-CHOP treated diffuse large B-cell lymphoma patients

A population-based study of the outcome for patients with first relapse of Hodgkin's lymphoma

A5.27 Ro52 Expression is a Prognostic Factor for Survival in B Cell Lymphoma

Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.

An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome

Autoimmune disease in patients with diffuse large B-cell lymphoma: occurrence and impact on outcome

BCL2 expression in de novo diffuse large B-cell lymphoma partly reflects normal differences in age distribution

Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.

Both CD4+ FoxP3+ and CD4+ FoxP3- T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro

Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB.

CAR T-Cell Therapy: The Role of Physical Barriers and Immunosuppression in Lymphoma

CD30 expression and survival in posttransplant lymphoproliferative disorders

CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma

Cancer of the parotid gland; long-term follow-up. A single centre experience on recurrence and survival

Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma

Cernunnos influences human immunoglobulin class switch recombination and may be associated with B cell lymphomagenesis

Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis

Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study

Chromosomal imbalances in diffuse large B-cell lymphoma detected by comparative genomic hybridization

Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope.

Classification of diffuse large B-cell lymphoma by immunohistochemistry demonstrates that elderly patients are more common in the non-GC subgroup and younger patients in the GC subgroup

Clonal development of a blastoid mantle cell lymphoma studied with comparative genomic hybridization

Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

Coding variants at hexa-allelic amino acid 13 of HLA-DRB1 explain independent SNP associations with follicular lymphoma risk

Core needle biopsies for the diagnosis of diffuse large B-cell lymphoma - a great concern for research

DNA repair genes are selectively mutated in diffuse large B cell lymphomas

Difficulties and bureaucracy threat against clinical research

Diffuse Large B Cell Lymphoma Cell Line U-2946: Model for MCL1 Inhibitor Testing

Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome?

Early and intermediate stage Hodgkin's lymphoma--report from the Swedish National Care Programme

Effect of eosinophil cationic protein (ECP) on Hodgkin lymphoma cell lines

Establishment of a cell line from a chemotherapy resistant diffuse large B-cell lymphoma

Estrogen receptor β1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker

Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis

Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients.

Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue

Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma

Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation

Expression of intratumoral forkhead box protein 3 in posttransplant lymphoproliferative disorders: clinical features and survival outcomes.

Expression of possible targets for new proteasome inhibitors in diffuse large B-cell lymphoma

Expression of ribosomal and actin network proteins and immunochemotherapy resistance in diffuse large B cell lymphoma patients.

Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis

Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapy

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma

Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia

Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma

Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas

Genetic variation in tumor necrosis factor and risk of diffuse large B-cell lymphoma and follicular lymphoma: differences between subgroups in Swedish patients

Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma

High Posttransplant Cancer Incidence in Renal Transplanted Patients With Pretransplant Cancer

High expression of microRNA-200c predicts poor clinical outcome in diffuse large B-cell lymphoma

High proportions of PD-1 and PD-L1 leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome

High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms

Hodgkin lymphoma--a survey of children and adolescents treated in Sweden 1985-2009.

Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade

IL-9 expression contributes to the cellular composition in Hodgkin lymphoma

In vitro and in vivo activity of melflufen (J1)in lymphoma

Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden

Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000-2013.

LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma

Long term risk of infections in Hodgkin lymphoma long‐term survivors ⬇️

Long-term risk of cardiovascular disease in Hodgkin lymphoma survivors--retrospective cohort analyses and a concept for prospective intervention

Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma

Low expression of microRNA-129-5p predicts poor clinical outcome in diffuse large B cell lymphoma (DLBCL)

Male gender is an adverse risk factor only in young patients with diffuse large B-cell lymphoma - a Swedish population-based study

Malignancies in transplanted patients: Multidisciplinary evaluation and switch to mTOR inhibitors after kidney transplantation - experiences from a prospective, clinical, observational study

Malignant lymphoma in granulomatosis with polyangiitis: subtypes, clinical characteristics and prognosis

Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion

Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma

Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma

Molecular cytogenetic characterization of four commonly used cell lines derived from Hodgkin lymphoma

Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma

No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy

Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma